Revolution Medicines, Inc. Human Resources Contracts & Agreements
19 Contracts & Agreements
- Bonus & Incentive Agreements (6 contracts)
- Compensation Agreements (5)
- Employment Agreements (8)
- Employment Agreement dated as of August 1, 2024 by and between Revolution Medicines, Inc. and Xiaolin Wang, Sc.D (Filed With SEC on August 7, 2024)
- Employment Agreement, dated as of August 1, 2024 by and between Revolution Medicines, Inc. and Jack Anders (Filed With SEC on August 7, 2024)
- Non-Employee Director Compensation Program (Filed With SEC on May 8, 2024)
- First Amendment to Employment Agreement dated June 10, 2022 by and between Revolution Medicines, Inc. and Mark Goldsmith, M.D., Ph.D (Filed With SEC on June 10, 2022)
- Employment Agreement by and between Revolution Medicines, Inc. and Xiaolin Wang Sc.D (Filed With SEC on May 9, 2022)
- Employment Agreement by and between Revolution Medicines, Inc. and Jack Anders (Filed With SEC on May 9, 2022)
- Non-Employee Director Compensation Program (Filed With SEC on May 9, 2022)
- Non-Employee Director Compensation Program (Filed With SEC on August 11, 2021)
- Non-Employee Director Compensation Program (Filed With SEC on July 6, 2020)
- Non-Employee Director Compensation Program (Filed With SEC on February 3, 2020)
- Form of Restricted Stock Unit Award Grant Notice under the 2020 Incentive Award Plan (Filed With SEC on February 3, 2020)
- Form of Restricted Stock Award Agreement under the 2020 Incentive Award Plan (Filed With SEC on February 3, 2020)
- Form of Stock Option Grant Notice and Stock Option Agreement under the 2020 Incentive Award Plan (Filed With SEC on February 3, 2020)
- 2020 Incentive Award Plan (Filed With SEC on February 3, 2020)
- Employment Agreement by and between Revolution Medicines, Inc. and Margaret Horn, J.D (Filed With SEC on January 17, 2020)
- Employment Agreement by and between Revolution Medicines, Inc. and Steve Kelsey, M.D., FRCP, FRCPath (Filed With SEC on January 17, 2020)
- Employment Agreement by and between Revolution Medicines, Inc. and Mark A. Goldsmith, M.D., Ph.D (Filed With SEC on January 17, 2020)
- Form of Amended and Restated Early Exercise Stock Option Grant Notice and Amended and Restated Stock Option Agreement under 2014 Equity Incentive Plan, as amended (Filed With SEC on January 17, 2020)
- 2014 Equity Incentive Plan, as amended (Filed With SEC on January 17, 2020)
